Summary
IDEXX Laboratories, Inc. (IDXX) reported solid revenue growth in the second quarter of 2016, with total revenue increasing by 12.9% year-over-year to $466.6 million. This growth was primarily driven by the Companion Animal Group (CAG) segment, which saw a 13.8% increase in revenue, largely due to strong performance in recurring diagnostics revenue, including reference laboratory services and consumables. The company demonstrated healthy operating income growth of 18.0%, reaching $104.2 million, with an operating margin of 22.3%. Net income attributable to stockholders also saw a significant increase, up 18.1% to $67.2 million, leading to diluted earnings per share of $0.74, an increase from $0.60 in the prior year. Financially, IDEXX maintained a strong liquidity position with cash and cash equivalents and marketable securities totaling $370.2 million. The company's cash flow from operations was robust, providing $134.1 million in the first six months of the year. While the company continued its share repurchase program, the pace moderated compared to the previous year, indicating a balanced approach to capital allocation. The company's outlook remains positive, with continued investment in growth areas and a focus on operational efficiency.
Financial Highlights
51 data points| Revenue | $466.57M |
| Cost of Revenue | $206.03M |
| Gross Profit | $260.54M |
| R&D Expenses | $25.41M |
| Operating Income | $104.16M |
| Interest Expense | $8.20M |
| Net Income | $67.20M |
| EPS (Basic) | $0.75 |
| EPS (Diluted) | $0.74 |
| Shares Outstanding (Basic) | 89.82M |
| Shares Outstanding (Diluted) | 90.82M |
Key Highlights
- 1Total revenue increased by 12.9% to $466.6 million for the three months ended June 30, 2016, compared to $413.3 million in the prior year.
- 2Companion Animal Group (CAG) revenue grew by 13.8% to $400.2 million, driven by strong demand for recurring diagnostics services and consumables.
- 3Operating income rose by 18.0% to $104.2 million, with operating margin improving to 22.3% from 21.4% in the prior year.
- 4Net income attributable to IDEXX stockholders increased by 18.1% to $67.2 million.
- 5Diluted earnings per share (EPS) improved to $0.74 from $0.60 in the same period last year.
- 6The company maintained a strong balance sheet with $370.2 million in cash, cash equivalents, and marketable securities as of June 30, 2016.
- 7Cash flow from operating activities for the six months ended June 30, 2016, was $134.1 million, a significant increase from $65.5 million in the prior year.